December 11, 2025

What Drives Progression Despite TNFi?

Study shows complement activation marker C3dg, MASP-1, and MASP-3 levels before tumor necrosis factor inhibitor therapy predicted new bone formation after 2 years of follow-up among axial spondyloarthritis patients with a high risk of radiographic progression.

Conexiant

December 10, 2025

A New Question for Chronic Pain

A new clinical feature–based self-referral tool shows promise for speeding the diagnosis of axial spondyloarthritis.

Conexiant

December 10, 2025

Medical Oddities: Hot Flashes, Prepare to Be Hypnotized

Your weekly grab bag: mouthwash spice, hypnotic cool-downs, muscle tea, fiber fixes, telomere buzz.

Conexiant

December 10, 2025

Dual Therapy Shows Bone Promise

Adding romosozumab to ongoing denosumab therapy boosted bone formation and improved spine density in postmenopausal women with severe osteoporosis.

Conexiant

December 08, 2025

RA Clues Detected Months Prior

Key markers signaled RA risk earlier than expected in relatives of adults with RA.

Conexiant

November 17, 2025

Are We Underrating Running in RA?

Despite recognizing physical and mental health advantages, rheumatologists identify evidence gaps and patient misconceptions as key obstacles — and call for RA-specific guidance.

Conexiant

November 05, 2025

Wait Time Equity Elusive in VHA Specialty Care

Over 10 million referrals revealed systemic inequities in access to care.

Conexiant

November 13, 2025

Allergies May Increase Surgical Risk

Researchers show that patients with allergies face higher postoperative risks.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant